Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Hematopoietic Stem Cell Transplant with Thiotepa-Based Conditioning for Adult T-ALL

Lu Zhao, Yuqing Liu, Ting Chen, Yimei Feng, Han Yao, Lidan Zhu, Jia Liu, Huanfeng Liu, Shichun Gao, Lu Wang, Shuhan Tang, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2024) 144 (Supplement 1): 7192.

https://doi.org/10.1182/blood-2024-205161

Published: 2024

Journal Articles

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

Han Yao, Xiaoqi Wang, Ruihao Huang, Yimei Feng, Xiaojuan Deng, Ting Chen, Lidan Zhu, Jia Liu, Yuqing Liu, Lu Zhao, Lu Wang, Cheng Zhang, Peiyan Kong, Li Gao, Lei Gao, Qifa Liu, Xiaohui Zhang, Xi Zhang

Blood (2024) 144 (Supplement 1): 7122.

https://doi.org/10.1182/blood-2024-206679

Published: 2024

Journal Articles

Efficacy and Safety of Decitabine Combined with FB3 As Conditional Regimen for Elderly/Frail Acute Myeloid Leukemia Patient with Allo-HSCT

Shichun Gao, Lidan Zhu, Jia Liu, Huanfeng Liu, Lu Wang, Peiyan Kong, Cheng Zhang, Li Gao, Ting Chen, Yimei Feng, Yuqing Liu, Han Yao, Lu Zhao, Lei Gao, Xi Zhang

Blood (2024) 144 (Supplement 1): 7317.

https://doi.org/10.1182/blood-2024-207037

Published: 2024

Journal Articles

Which Patients Will Benefit More?–the Impact of Different Biological Characteristics of High-Risk Acute Myeloid Leukemia on the Efficacy of Maintenance Treatment with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation

Jia Liu, Lidan Zhu, Huanfeng Liu, Shichun Gao, Lu Wang, Peiyan Kong, Xi Zhang, Lei Gao

Blood (2024) 144 (Supplement 1): 7435.

https://doi.org/10.1182/blood-2024-207733

Published: 2024

Journal Articles

Clinical Study on the Treatment of Poor Erythroid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation with Luspatercept

Lidan Zhu, Jia Liu, Huanfeng Liu, Shichun Gao, Lu Wang, Peiyan Kong, Xi Zhang, Lei Gao

Blood (2024) 144 (Supplement 1): 2159.

https://doi.org/10.1182/blood-2024-206379

Published: 2024

Journal Articles

Survival and Risk Prediction Model for Acute Leukemia Patientsundergoing Hematopoietic Stem Cell Transplantation

Xiaoli Chen, Yimei Feng, Jie Tang, Lin Xia, Shanshan Du, Feng Ran, Liquan Jiang, Lei Gao, Xi Zhang

Blood (2024) 144 (Supplement 1): 7450.

https://doi.org/10.1182/blood-2024-207410

Published: 2024

Journal Articles

Safety and Efficacy of Pomalidomide and Azacitidine Combination in MRD-Guided Preemptive Treatment of Acute Leukemia after Allogeneic Stem Cell Transplantation

Lu Wang, Jia Liu, Lidan Zhu, Huanfeng Liu, Shichun Gao, Peiyan Kong, Xi Zhang, Lei Gao

Blood (2024) 144 (Supplement 1): 6176.

https://doi.org/10.1182/blood-2024-205435

Published: 2024

Journal Articles

Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease

Zengkai Pan, Yujun Deng, Jingtao Huang, Aijie Huang, Xiong Ni, Lei Gao, Chuanhe Jiang, Luxiang Wang, Zilu Zhang, Quan Gu, Hui Cheng, Jianmin Wang, Hongbo Hu, Xiaoxia Hu

Blood (2024) 144 (Supplement 1): 101.

https://doi.org/10.1182/blood-2024-200811

Published: 2024

Journal Articles

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

James K. Godfrey, Lei Gao, Geoffrey Shouse, Joo Y. Song, Stacy Pak, Brian Lee, Bihong T. Chen, Avyakta Kallam, John H. Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V. Danilov, Alex F. Herrera, Larry W. Kwak, Lihua E. Budde

Blood (2024) 144 (4): 457–461.

https://doi.org/10.1182/blood.2024024168

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial

Yimei Feng, Linhui Wang, Tao Lang, Mingqiang Ren, Hai Yi, Jianchuan Deng, Liangliang Ma, Hongyun Xing, Dan Wang, Han Yao, Ting Chen, Yuqing Liu, Lidan Zhu, Jia Liu, Shichun Gao, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 3539.

https://doi.org/10.1182/blood-2023-188481

Published: 2023

Journal Articles

Efficacy and Safety of Herombopag for the Treatment of Secondary Failure of Platelet Recovery after Allogeneic Hematopoietic Stem Cell Transplantation: The Single Center Prospective Study from China

Huanfeng Liu, Lidan Zhu, Jia Liu, Shichun Gao, Lu Wang, Peiyan Kong, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 6967.

https://doi.org/10.1182/blood-2023-188407

Published: 2023

Journal Articles

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Blood (2023) 142 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2023-189104

Published: 2023

Journal Articles

Effect of Pre-Transplantation Nutritional Status on the Early Related Complications of Allogeneic Hematopoietic Stem Cell Transplantation:a Cohort Study

Fangfang Wu, Shanshan Du, Xin Du, Rufu Xu, Aihua Sun, Peiyan Kong, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 5103.

https://doi.org/10.1182/blood-2023-188646

Published: 2023

Journal Articles

Application Gene Variation Detection before and after Hematopoietic Stem Cell Transplantation to Predict the Relapse of Hematopoietic Neoplasm Patients after Transplantation: Retrospective Data from a Single Center in China

Jia Liu, Peiyan Kong, Lidan Zhu, Shichun Gao, Lu Wang, Huanfeng Liu, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang

Blood (2023) 142 (Supplement 1): 6975.

https://doi.org/10.1182/blood-2023-188458

Published: 2023

Journal Articles

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood (2023) 142 (16): 1359–1370.

https://doi.org/10.1182/blood.2023020485

Published: 2023

Includes: Supplemental data

Journal Articles

Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial

Ruihao Huang, Qin Wen, Xiaoqi Wang, Hongju Yan, Yingying Ma, Wang Mai-Hong, Xiao Han, Li Gao, Lei Gao, Cheng Zhang, Xi Zhang

Blood (2022) 140 (Supplement 1): 7450–7451.

https://doi.org/10.1182/blood-2022-170712

Published: 2022

Journal Articles

Efficacy and Safety of Azacytidine Combined with Low-Dose Lenalidomide in Preemptive Treatment of Post Allo-SCT Acute Myeloid Leukemia Patients with Detectable Minimal Residual Disease

Lu Wang, Yimei Feng, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2022) 140 (Supplement 1): 12933.

https://doi.org/10.1182/blood-2022-168641

Published: 2022

Journal Articles

Decitabine Combined with FB3 As Conditional Regimen for Elderly/Weak Acute Myeloid Leukemia Patient with Allo-HSCT

Shichun Gao, Peiyan Kong, Lidan Zhu, Jia Liu, Liu Huanfeng, Lu Wang, Cheng Zhang, Li Gao, Lei Gao, Xi Zhang

Blood (2022) 140 (Supplement 1): 12835–12836.

https://doi.org/10.1182/blood-2022-169384

Published: 2022

Journal Articles

Efficiency and Toxicity of Imatinib Mesylate Combined with Atorvastatin Calcium for Steroid-Refractory Chronic Graft-Versus-Host Disease

Ting Chen, Han Yao, Yuqing Liu, Lidan Zhu, Jia Liu, Liu Huanfeng, Shichun Gao, Lu Wang, Lu Zhao, Yimei Feng, Lei Gao, Xi Zhang, Peiyan Kong

Blood (2022) 140 (Supplement 1): 4784–4785.

https://doi.org/10.1182/blood-2022-169673

Published: 2022

Journal Articles

Combination Azacitidine and Lenalidomide: A Novel Relapse Prophylaxis Option in Patients after Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

Yimei Feng, Lu Wang, Ting Chen, Han Yao, Yun Zhang, Yuqing Liu, Lu Zhao, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2022) 140 (Supplement 1): 4894.

https://doi.org/10.1182/blood-2022-169465

Published: 2022

NARROW

Hematopoietic Stem Cell Transplant with Thiotepa-Based Conditioning for Adult T-ALL

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

Efficacy and Safety of Decitabine Combined with FB3 As Conditional Regimen for Elderly/Frail Acute Myeloid Leukemia Patient with Allo-HSCT

Which Patients Will Benefit More?–the Impact of Different Biological Characteristics of High-Risk Acute Myeloid Leukemia on the Efficacy of Maintenance Treatment with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Study on the Treatment of Poor Erythroid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation with Luspatercept

Survival and Risk Prediction Model for Acute Leukemia Patientsundergoing Hematopoietic Stem Cell Transplantation

Safety and Efficacy of Pomalidomide and Azacitidine Combination in MRD-Guided Preemptive Treatment of Acute Leukemia after Allogeneic Stem Cell Transplantation

Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial

Efficacy and Safety of Herombopag for the Treatment of Secondary Failure of Platelet Recovery after Allogeneic Hematopoietic Stem Cell Transplantation: The Single Center Prospective Study from China

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Effect of Pre-Transplantation Nutritional Status on the Early Related Complications of Allogeneic Hematopoietic Stem Cell Transplantation:a Cohort Study

Application Gene Variation Detection before and after Hematopoietic Stem Cell Transplantation to Predict the Relapse of Hematopoietic Neoplasm Patients after Transplantation: Retrospective Data from a Single Center in China

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial

Efficacy and Safety of Azacytidine Combined with Low-Dose Lenalidomide in Preemptive Treatment of Post Allo-SCT Acute Myeloid Leukemia Patients with Detectable Minimal Residual Disease

Decitabine Combined with FB3 As Conditional Regimen for Elderly/Weak Acute Myeloid Leukemia Patient with Allo-HSCT

Efficiency and Toxicity of Imatinib Mesylate Combined with Atorvastatin Calcium for Steroid-Refractory Chronic Graft-Versus-Host Disease

Combination Azacitidine and Lenalidomide: A Novel Relapse Prophylaxis Option in Patients after Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only